Matthew M. Hutmacher

Decision-Making in Drug Development: Application of a Model Based Framework for Assessing Trial Performance

Jonathan French, Kenneth G. Kowalski, Mike K. Smith, 2011 .

Evaluation of Random Sparse Sampling Designs for a Population Pharmacokinetic Study: Assessment of Power and Bias Using Simulation

Kenneth G. Kowalski, Matthew M. Hutmacher, 2002 .

An alternative method for population pharmacokinetic data analysis under noncompliance

Raymond Miller, Pankaj Gupta, Matthew M. Hutmacher, 2008, Journal of Pharmacokinetics and Pharmacodynamics.

Evaluation of Random Sparse Sampling Designs for a Population Pharmacokinetic Study: Assessment of Power and Bias Using Simulation

Kenneth G. Kowalski, Matthew M. Hutmacher, M. Hutmacher, 2002 .

Predicting Relapsing-Remitting Dynamics in Multiple Sclerosis Using Discrete Distribution Models: A Population Approach

Joaquín Goñi, Pablo Villoslada, Iñaki F. Troconiz, 2013, PloS one.

A Two-Part Mixture Model for Longitudinal Adverse Event Severity Data

Lynn McFadyen, Kenneth G. Kowalski, Matthew M. Hutmacher, 2003, Journal of Pharmacokinetics and Pharmacodynamics.

Extending the latent variable model for extra correlated longitudinal dichotomous responses

Matthew M. Hutmacher, J. French, M. Hutmacher, 2011, Journal of Pharmacokinetics and Pharmacodynamics.

Joint modeling of dizziness, drowsiness, and dropout associated with pregabalin and placebo treatment of generalized anxiety disorder

Matthew M. Hutmacher, Bill Frame, Raymond Miller, 2009, Journal of Pharmacokinetics and Pharmacodynamics.